We aimed to evaluate the diagnostic values of soluble transferrin receptor (sTfR) concentration, transferrin-ferritin index (soluble transferrin receptor concentration/log ferritin), ferritin levels and other related parameters in geriatric patients with anemia of chronic disease (ACD) and iron deficiency (IDA). Forty-four elderly subjects (median age 73 ) and twenty healthy subjects (median age 49 [44][45][46][47][48][49][50][51][52][53][54][55][56]) were enrolled into this study, divided into four groups: twenty middle aged healthy subjects (group A), fifteen elderly patients with IDA (group B), fourteen elderly patients with ACD (group C) and fifteen nonanemic geriatric subjects (group D). Hemoglobin, mean corpuscular volume, serum iron concentration and transferrin saturation levels of the patients in IDA group were found significantly lower than those in both non-anemic group and healthy subjects. Serum sTfR concentrations of the patients in IDA group were significantly higher than those in non-anemic geriatric group, ACD group and healthy subjects. Transferrin-ferritin index of the patients with IDA was significantly higher than that in non-anemic geriatric and ACD group. Serum ferritin levels of the patients in IDA group did not show any differences when compared with the other groups. Serum ferritin was highly specific for IDA (95%) when compared with ACD, although its sensitivity was low (38%). STfR values were negatively correlated with both transferrin and ferritin levels (p=0.042 r=−0.40; and p=0.034 r= −0.41, respectively). In conclusion, serum soluble transferrin receptor and transferrin-ferritin index may be used together with serum ferritin to distinguish the iron deficiency state in the elderly.
The transferrin receptor (TfR) is a cellular transmembranous protein found especially on cells requiring large amounts of iron such as hemoglobin synthesizing cells of reticuloendothelial system (RES) and placenta. Iron delivery to erythroblast is mediated by the interaction of plasma transferrin with the cell surface transferrin receptors (TfRs) (Huebers and Finch 1987; Cook et al. 1993) . A soluble form of TfR, which is derived from the proteolytic cleavage of the extracellular segment (Shih et al. 1990; Rutledge et al. 1994 ) has been demonstrated in serum (Kohgo et al. 1986 ). In recent years, the soluble serum transferrin receptor (sTfR) has been introduced as a promising new index for iron depletion. The main clinical use of sTfR measurement has been demonstrated in the assessment of erythropoietic activity (Kohgo et al. 1987; Huebers et al. 1990 ), functional iron deficiency Baynes 1996a) , and in distinguising the iron deficiency from the anemia of chronic diseases (ACD).
Ferritin is another protein that participates in iron homeostasis (Kühn 1994) . In any inflammation, a cytokine-mediated pathway can activate the ferritin gene causing hyperferritinemia (Konjin 1994) . In general practice with geriatric patients, iron deficiency is often associated with inflammatory features, with the result that the typical iron pattern of iron deficiency anemia can be mixed with the iron pattern of anemia of chronic disorders (Cartwright and Lee 1971) .
In this study, we aimed to evaluate the diagnostic values of sTfR concentration, TfR-ferritin index, ferritin levels and other related parameters in geriatric patients with ACD and IDA.
MATERIALS AND METHODS
Fourty-four elderly (women 23, men 21, median age 73 ) and twenty middle-aged healthy subjects (women 11, men 9, median age 49 [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] ) enrolled into this study, divided into four groups as follows: 20 middle-aged healthy subjects (group A), 15 elderly patients with IDA (group B), 14 elderly patients with ACD (group C) and 15 non-anemic geriatric subjects (group D). Patients with anemia due to a hematological malignancy, hemolytic anemia, vitamin B12 or folate deficiency and those received iron supplement were excluded. Anemia was defined as a blood hemoglobin level <130 g/liter in men and <120 g/liter in women. IDA was diagnosed when transferrin saturation % (TS) of the patients was <15% (Fairbank and Beutler 2001) . Anemia of chronic diseases was diagnosed when there is mild to moderate anemia in association with infectious, inflammatory, traumatic or neoplastic diseases that persisted for more than 1 months with no evidence of IDA or other causes of anemia (Bentley 1982 ) were determined using Sysmex SE 9000 automated analyzer. Serum iron concentration (SIC), total iron binding capacity (TIBC), serum ferritin concentration were determined by E170 autoanalyzer. Serum transferrin, sTfR and C-reactive protein (CRP) concentrations were measured by Cobas Integra 400 analyzer. All equipments were from Roche. Reference values of our laboratory were 50-175 μ g/100 ml for SIC, 250-410 μ g/100 ml for TIBC, <5 mg/liter for CRP, 30-400 ng/ml in men and 13-150 ng/ml in women for ferritin. Transferrin saturation (%TS) was calculated using the formula TS%=100× SIC/ TIBC and Transferrin-ferritin index was estimated with soluble transferrin receptor concentration/log ferritin. Statistical analyses were performed by using Unpaired student t-test, Mann Whitney's U-test, Pearson test was used for correlation analyses. Receiver operation characteristic (ROC) curve analysis was used to assess the diagnostic values of variables for the determination of iron deficiency anemia. Informed consents of the patients were taken before the study, and this study was approved by the local institutional ethics committee. 
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RESULTS
Results obtained from the four groups of subjects are summarized in Table 1 . Five patients with metastatic neoplastic disease (3 rectum adenocarcinoma, 2 prostate carcinoma), 3 patients with diabetes mellitus, 3 patients with ischemic heart disease, 2 patients with Parkinson's disease and one patient with hyperparathyroidism were included in ACD group. Hb, MCV, SIC, TS% levels in IDA group were found significantly lower than those in both non-anemic geriatric group and healthy subjects (p<0.001). Hb, MCV, SIC, TS% levels in IDA group were significantly lower than the levels in healthy control group (p<0.001). Meanwhile, no significant difference was found between IDA and ACD when MCV, Hb and serum transferrin were taken into consideration (Table 2) . Soluble TfR concentration and transferrin-ferritin index in IDA group were statistically significant than that in healthy control group and ACD group (IDA vs. control, p=0.001 and p=0.003; IDA vs. ACD, p=0.024 and p=0.018). Serum ferritin level in IDA group did not show any difference when compared with the other groups. Mean serum CRP levels in IDA group was 25.34±7.21 mg/liter (0-5 mg/liter), and 11/15 of these patients had high serum CRP levels. Statistically significant differences in transferrin concentrations were determined between both IDA group and healthy subjects (p=0.002) and between ACD group and healthy subjects (p<0.001) ( Table 2) .
The best cut-off point was defined as 4.5 mg/ liter for sTfR and 40 ng/ml for ferritin. These figures correspond to a specificity of 67%, sensitivity of 77%, positive predictive value 0.91, negative predictive value 0.67, diagnostic value 73 for sTfR and a specificity of 100%, sensitivity of 38%, positive predictive value 1.00, negative predictive value 0.53 and diagnostic value 64 for serum ferritin (Fig. 1A) . sTfR values were negatively correlated with both transferrin and ferritin levels (p=0.042 r=−0.40; and p=0.034 r=−0.41 respectively).
Sensitivity, specificity, positive predictive and diagnostic values of hemoglobin, MCV and serum transferrin in the diagnosis of iron deficiency anemia were statistically insignificant (Hb, 0.62, 0.45, 0.57 and 53; MCV, 0.78, 0.60, 0.78 and 71; Transferrin, 0.62, 0.30, 0.53 and 48) . However, transferrin-ferritin index was found significant in the diagnosis of iron deficiency anemia in elderly people (sensitivity, 0.69; specificity, 0.78; positive predictive value, 0.81 and diagnostic value, 73) ( Fig. 1) .
DISCUSSION
Standart laboratory indices of iron status does not always help to distinguish IDA from ACD in geriatric patients. In the present study, we determined sTfR levels and transferrinferritin index and evaluated the diagnostic value of these parameters in geriatric patients with IDA and ACD. Evaluation of the iron deficit can be achieved by measuring serum soluble TfR concentration since the expression of TfR by the reticulo-endothelial system is directly proportional to cellular iron demand, and the circulating levels of sTfR reflecting the amount of cellular TfRs (Rao et al. 1985; Skikne et al. 1990; Pietrangelio et al. 1992; Cook et al. 1993) . In this study, sTfR levels of the patients in IDA group were found increased when compared with the other groups studied. This observation is in good agreement with that reported by Ho and Punnonen (Punnonen et al. 1994; Ho 2002) . However, elevated serum sTfR levels in ACD was also reported by other researchers those suggested that sTfR is not superior to the serum ferritin for distinguishing IDA from ACD (Pettersson et al. 1994; North et al. 1997; Mast et al.1998; Joosten et al. 2002) .
Both serum ferritin and sTfR levels are known to undergo a characteristic sequence of changes, as body iron stores decrease from normal iron-replete levels to those found in IDA (Cook 1982; Hastka et al. 1996) . During depletion phase, serum transferrin receptor concentration remains stable while ferritin level shows a progressive decrease. When the storage deficit is sufficient to restrict the synthesis of hemoglo-bin and other functional iron compounds, iron deficient erythropoiesis ensues. Early indicator of this stage is the compensatory elevated sTfR concentration (Skikne et al.1990; Baynes 1996b) . Finally, IDA develops as the hemoglobin concentration falls below the lower limit of normal as a result of progressive depletion of functional iron compartment. With the depletion of functional compartment, transferrin receptor level begins to increase as ferritin remains constant at reduced level. Additionaly, serum ferritin level reflects iron storage compartment and transferrin receptor level reflects functional iron (Baynes 1996a) . These two values can be combined into a ratio, which is reciprocally regulated sTfR/ ferritin or sTfR/ log ferritin index, has already been used in differential diagnosis of IDA Ferguson et al. 1992; Pietrangelio et al. 1992; Baynes 1996a, b; Punnonen et al. 1997) . It was proposed that transferrin-ferritin index is a good marker for the diagnosis of IDA in the elderly as well as in the younger population (Nielsen et al. 1994; Punnonen et al. 1997; Cermak and Brabec 1998; Rimon et al. 2002) . In our study, both sTfR and transferrin-ferritin index was found higher in patients with IDA than that in patients with ACD (sTfR, 5.76±0.76 vs. 3.31±0.47 mg/liter, p=0.024; transferrin-ferritin index, 3.48±0.54 vs. 1.68± 0.27, p=0.018), non-anemic geriatric and healthy middle-aged subjects. ROC curve analysis indicated that the sTfR and transferrin-ferritin index provided the highest diagnostic accuracy for discriminating between individuals in IDA and ACD (Fig. 1) . These data correlate with the findings reported by Remacha et al. (1998) , Means et al. (1999) , Wians et al. (2001) and Rimon et al. (2002) . Joosten et al. (2002) suggested that serum ferritin level was a better marker than sTfR in the assessment of iron status. Depending our findings, serum ferritin concentrations were found similar in all groups, although serum transferrin levels of the ACD and IDA groups were significantly different when compared with the healthy controls. Serum levels of ferritin increases in chronic disorders and in malignancy which are more frequent in elderly (Loria et al. 1979 ) and also has tendecy to increase with age (Casale et al. 1981; Witte 1991) . However, acute phase responses make the interpretation of the laboratory data difficult, given that both serum ferritin and serum transferrin are acute phase reactants, the former increases and latter decreases in acute inflammation (Leggett et al. 1990; Coenen et al. 1991; Witte 1991) . Although sensitivity of serum ferritin in the assessment of iron deficiency anemia was found low (38%) in our study, its specificity was vey high (95%) and the diagnostic value was 75.
Increased serum C-reactive protein levels (>5 mg/liter) were found in 73% of the patients in IDA group (25.34±7.21, [1.34-60 .10] mg/liter) and 70% of the patients in ACD group (35.63± 12.42, [12.7-113 .2] mg/liter). Anemia of chronic inflammatory disease can be seen in elderly people, and the only way to improve anemia in this condition is the treatment of the chronic disease. However, existence of the iron deficiency anemia needs treatment with oral or parenteral iron. So the diagnosis of an iron deficiency state is very important. In this study, our aim is to diagnose iron deficiency state in elderly for the appropriate treatment. In our IDA group, some of our patients had high CRP and ferritin levels those might be related with the existence of unknown chronic diseases. We discriminated those patients as IDA group for they had evidence of iron deficiency either with or without chronic disease anemia.
In conclusion, serum soluble transferrin receptor and transferrin-ferritin index may be used together with serum ferritin to distinguish the iron deficiency state in the elderly.
